{"url":"https://www.moneycontrol.com/news/business/lupin-launches-generic-drug-in-us-market-2-12691921.html","title":"Lupin launches generic drug in US market","description":"The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.Lupin launches generic drug in US market","content":"Drug maker Lupin on Monday said it has launched Mirabegron extended-release tablets (25 mg) in the US market. The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement. The company's product is a generic equivalent of Astellas Pharma Global Development, Inc's Myrbetriq extended-release tablets, it added. Lupin shares were trading 3.38 percent up at Rs 1,599.35 apiece on the BSE. ","cleaned_content":"drug maker lupin on monday said it has launched mirabegron extended release tablets \u003cTWO_TEN\u003e mg in the us market the mumbai based drug maker has introduced the medication after receiving an approval from the us food and drug administration usfda lupin said in a statement the companys product is a generic equivalent of astellas pharma global development incs myrbetriq extended release tablets it added lupin shares were trading \u003cTHREE_PERCENT\u003e up at rs \u003cONE_THOUSAND\u003e apiece on the bse","timestamp":"2024-04-22T12:38:00+05:30","market_timestamp":"2024-04-22T12:38:00+05:30","off_market_hours":false}